Pharmacist Disciplinary Action: What Do Pharmacists Get in Trouble for?
Journal
Healthcare policy = Politiques de sante
ISSN: 1715-6580
Titre abrégé: Healthc Policy
Pays: Canada
ID NLM: 101280107
Informations de publication
Date de publication:
02 2023
02 2023
Historique:
pmc-release:
01
02
2024
entrez:
14
3
2023
pubmed:
15
3
2023
medline:
17
3
2023
Statut:
ppublish
Résumé
This study aims to determine the reasons for disciplinary action and resultant consequences for Canadian pharmacists and any associations with demographic factors. Regulatory body disciplinary action cases from 10 Canadian provinces were coded. Demographic information was coded. There were 665 pharmacist cases from nine provinces between January 2010 and December 2020. The rate of disciplinary action was low (1.37 cases/1,000 practitioners/year). Professional misconduct was the most common category of violation. Male pharmacists were overrepresented in disciplinary action cases. Most cases involved community pharmacists. This study is the first, to our knowledge, in Canada to analyze the demographic factors of pharmacists subjected to disciplinary action. It updates a previous review of pharmacist disciplinary action (Foong et al. 2018).
Identifiants
pubmed: 36917454
pii: hcpol.2023.27034
doi: 10.12927/hcpol.2023.27034
pmc: PMC10019516
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
60-71Subventions
Organisme : CIHR
Pays : Canada
Informations de copyright
Copyright © 2022 Longwoods Publishing.
Références
Aust Health Rev. 2020 Feb;44(1):15-23
pubmed: 31658934
BMJ Qual Saf. 2017 Mar;26(3):200-208
pubmed: 27009311
Pharm World Sci. 2003 Apr;25(2):43-51
pubmed: 12774563
BMC Med. 2015 Aug 13;13:172
pubmed: 26268807
CMAJ. 2018 Nov 26;190(47):E1398-E1399
pubmed: 30478222
Open Med. 2011;5(4):e166-72
pubmed: 22567070
J Am Dent Assoc. 1993 May;124(5):113-31
pubmed: 8482767
BMC Med. 2016 Dec 2;14(1):198
pubmed: 27908294
J Dent Educ. 2016 Jan;80(1):14-22
pubmed: 26729680
Can Pharm J (Ott). 2018 Aug 17;151(5):332-344
pubmed: 31080533